Methemoglobinemia after sodium nitroprusside therapy.
D005292:Ferricyanides / Q000009:adverse effects*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009599:Nitroprusside / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D005292:Ferricyanides; D009599:Nitroprusside